Literature DB >> 9892595

Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage.

E Lutgens1, M Daemen, M Kockx, P Doevendans, M Hofker, L Havekes, H Wellens, E D de Muinck.   

Abstract

BACKGROUND: This study documents (1) the progression of atherosclerosis along the entire arterial tree in APOE*3-Leiden mice after 1, 4, 6, 9, and 12 months of a high-fat/high-cholesterol (HFC) diet and (2) the amount and phenotype of DNA-synthesizing and apoptotic cells in different lesion types after 6 months of HFC diet. METHODS AND
RESULTS: Diet duration was correlated with a craniocaudal progression of lesion development and with an increase in severity of the lesion. Typically, the lesions contained smooth muscle cells, macrophages, and T lymphocytes and were covered by an intact endothelium. Whereas DNA synthesis (BrdU uptake) was usually elevated in type II lesions (8.6+/-0.8% versus 1.0+/-0.2% in the nondiseased arterial wall; P<0.05), apoptosis was found primarily in advanced lesions (type IV, 1.3+/-0.1% and type V, 1.2+/-0.2% versus 0.04+/-0.04% in the nondiseased arterial wall [P<0.05]). Cell phenotyping revealed that the majority of DNA synthesis and apoptosis was confined to the macrophage-derived foam cell (68.6+/-3. 0% and 82.2+/-4.6%, respectively).
CONCLUSIONS: This study shows that in APOE*3-Leiden mice, duration of an HFC diet is associated with (1) a craniocaudal progression of lesion development and (2) an increased complexity of atherosclerotic lesions. Furthermore, DNA synthesis is predominant in early lesions, whereas apoptosis is present mainly in more advanced lesions. Both parameters of cell turnover are confined primarily to the macrophage-derived foam cell.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892595     DOI: 10.1161/01.cir.99.2.276

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  28 in total

1.  The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit.

Authors:  M Kliffen; E Lutgens; M J Daemen; E D de Muinck; C M Mooy; P T de Jong
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

Review 2.  Lifestyle effects on hematopoiesis and atherosclerosis.

Authors:  Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2015-02-27       Impact factor: 17.367

Review 3.  Plant science and human nutrition: challenges in assessing health-promoting properties of phytochemicals.

Authors:  Maria H Traka; Richard F Mithen
Journal:  Plant Cell       Date:  2011-07-29       Impact factor: 11.277

Review 4.  Varied biologic functions of C-reactive protein: lessons learned from transgenic mice.

Authors:  Alexander J Szalai; Mark A McCrory
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 5.  Animal models of atherosclerosis.

Authors:  Fatemeh Ramezani Kapourchali; Gangadaran Surendiran; Li Chen; Elisabeth Uitz; Babak Bahadori; Mohammed H Moghadasian
Journal:  World J Clin Cases       Date:  2014-05-16       Impact factor: 1.337

Review 6.  Apoptosis and oncosis in acute coronary syndromes: assessment and implications.

Authors:  Bodh I Jugdutt; Halliday A Idikio
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

Review 7.  From proliferation to proliferation: monocyte lineage comes full circle.

Authors:  Filip K Swirski; Ingo Hilgendorf; Clinton S Robbins
Journal:  Semin Immunopathol       Date:  2014-01-17       Impact factor: 9.623

8.  P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Pieter-Jan D F Guns; Jan Hendrickx; Tim Van Assche; Paul Fransen; Hidde Bult
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739

9.  Substrate elasticity regulates the behavior of human monocyte-derived macrophages.

Authors:  Katrina M Adlerz; Helim Aranda-Espinoza; Heather N Hayenga
Journal:  Eur Biophys J       Date:  2015-11-27       Impact factor: 1.733

Review 10.  Development and Function of Arterial and Cardiac Macrophages.

Authors:  Filip K Swirski; Clinton S Robbins; Matthias Nahrendorf
Journal:  Trends Immunol       Date:  2016-01       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.